1002 Intratumor heterogeneity in MHC-I expression drives immunotherapy resistance and exposes NKG2A as a therapeutic target in breast cancer

1002 Intratumor heterogeneity in MHC-I expression drives immunotherapy resistance and exposes NKG2A as a therapeutic target in breast cancer

Bibliographic Details
Main Authors: Violeta Sánchez, Justin M Balko, Elizabeth Wescott, Melinda Sanders, Xiaopeng Sun, Susan Opalenik, Brandie C Taylor, Paula Gonzalez Ericsson, Ann Hanna, Brian Lehmann, Vandana Abramson, Jennifer Pietenpol
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer

Similar Items